Biotech Late Stage Investors & VC Firms
90 firms in this list, with a median first check of $4.1M. 25 of them lead rounds. Generated from verified public data and updated continuously.
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage
Longitude Capital
Menlo ParkSeries A–Late Stage
Adjuvant Capital
New YorkSeries A–Late Stage
JAZZ Venture Partners
San FranciscoSeed–Late Stage
Hikma Ventures
Seed–Late Stage$5M
Takeda Ventures
Pre-Seed–Late Stage
Blindspot Ventures Management Co
BostonPre-Seed–Late Stage
EUREKA! Venture
Seed–Late Stage
Lumira Ventures
Toronto, OntarioPre-Seed–Late Stage
BOLD Longevity
BostonLate Stage
NSV
GreenwichSeed–Late Stage
redalpine
ZurichSeed–Late Stage
LVX Ventures
IndiaPre-Seed–Late Stage
The Column Group
San FranciscoPre-Seed–Late Stage
Rock Springs Capital
BaltimoreLate Stage
OCV Partners
Los AngelesPre-Seed–Late Stage
Kinnevik
StockholmSeries A–Late Stage
InVivium Capital
ChicagoSeed–Late Stage
Vertex Ventures China
SingaporePre-Seed–Late Stage
Fundamental Ventures
LakewayPre-Seed–Late Stage
Gobi Partners
Hong KongPre-Seed–Late Stage
Avego BioScience Capital
AlpharettaSeries B–Late Stage
PBM Capital
CharlottesvilleSeed–Late Stage
Octave Ventures Llc
HendersonPre-Seed–Late Stage
Related lists
Late Stage Investors & VC Firms (1479)Biotech Investors & VC Firms (320)Biotech Seed Investors & VC Firms (255)Biotech Series A Investors & VC Firms (228)Biotech Pre-Seed Investors & VC Firms (153)Biotech Series B Investors & VC Firms (148)AI & Machine Learning Late Stage Investors & VC Firms (146)Healthtech Late Stage Investors & VC Firms (118)Biotech Growth Investors & VC Firms (104)Fintech Late Stage Investors & VC Firms (98)
Data sourced from public filings and firms' own websites — see our methodology.